摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2,4-dioxo-1H-benzo[d][1,3]oxazine-7-carboxylate | 926303-76-6

中文名称
——
中文别名
——
英文名称
methyl 2,4-dioxo-1H-benzo[d][1,3]oxazine-7-carboxylate
英文别名
5-methoxycarbonylisatoic anhydride;4-carboxymethyl isatoic anhydride;Methyl 1,4-dihydro-2,4-dioxo-2H-3,1-benzoxazine-7-carboxylate;methyl 2,4-dioxo-1H-3,1-benzoxazine-7-carboxylate
methyl 2,4-dioxo-1H-benzo[d][1,3]oxazine-7-carboxylate化学式
CAS
926303-76-6
化学式
C10H7NO5
mdl
——
分子量
221.169
InChiKey
NHZXTKWCFWVPJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    81.7
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • NEUROTRYPSIN INHIBITORS
    申请人:Ahmed Shaheen
    公开号:US20130261130A1
    公开(公告)日:2013-10-03
    The invention relates to acylamino-phthalic acid amides and related compounds of formula (I) wherein A is —CON—R 3 R 4 , —NR 5 COR 6 , —NHR 7 , —OR 8 , —SR 9 , —CH 2 NR 10 R 11 , —(CH2)2-R 12 , —CH═CH—R 12 , —C≡C—R 12 , optionally substituted phenyl, optionally substituted thiophenyl, or optionally substituted 1,2,3-triazol-4-yl, W is hydrogen, hydroxy or carboxymethoxy, Y is carboxy, methoxycarbonyl or 2H-tetrazol-5-yl, and the various substituents R have the meanings indicated in the description. These compounds are useful for the treatment and/or prophylaxis of skeletal muscle atrophy, schizophrenia and Alzheimer's disease, and as cognitive enhancers.
    本发明涉及式(I)的酰胺基苯甲酸和相关化合物,其中A为—CON—R3R4,—NR5COR6,—NHR7,—OR8,—SR9,—CH2NR10R11,—(CH2)2-R12,—CH═CH—R12,—C≡C—R12,可选取代苯基,可选取代噻吩基,或可选取代1,2,3-三唑-4-基;W为氢、羟基或羧甲氧基;Y为羧基、甲氧羰基或2H-四唑-5-基;各取代基R的含义如说明中所示。这些化合物可用于治疗和/或预防骨骼肌萎缩、精神分裂症和阿尔茨海默病,并作为认知增强剂。
  • Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
    作者:Luca Costantino、Stefania Ferrari、Matteo Santucci、Outi MH Salo-Ahen、Emanuele Carosati、Silvia Franchini、Angela Lauriola、Cecilia Pozzi、Matteo Trande、Gaia Gozzi、Puneet Saxena、Giuseppe Cannazza、Lorena Losi、Daniela Cardinale、Alberto Venturelli、Antonio Quotadamo、Pasquale Linciano、Lorenzo Tagliazucchi、Maria Gaetana Moschella、Remo Guerrini、Salvatore Pacifico、Rosaria Luciani、Filippo Genovese、Stefan Henrich、Silvia Alboni、Nuno Santarem、Anabela da Silva Cordeiro、Elisa Giovannetti、Godefridus J Peters、Paolo Pinton、Alessandro Rimessi、Gabriele Cruciani、Robert M Stroud、Rebecca C Wade、Stefano Mangani、Gaetano Marverti、Domenico D'Arca、Glauco Ponterini、Maria Paola Costi
    DOI:10.7554/elife.73862
    日期:——

    Drugs that target human thymidylate synthase (hTS), a dimeric enzyme, are widely used in anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors induces over-expression of this protein and development of drug resistance. We thus pursued an alternative strategy that led us to the discovery of TS-dimer destabilizers. These compounds bind at the monomer-monomer interface and shift the dimerization equilibrium of both the recombinant and the intracellular protein toward the inactive monomers. A structural, spectroscopic, and kinetic investigation has provided evidence and quantitative information on the effects of the interaction of these small molecules with hTS. Focusing on the best among them, E7, we have shown that it inhibits hTS in cancer cells and accelerates its proteasomal degradation, thus causing a decrease in the enzyme intracellular level. E7 also showed a superior anticancer profile to fluorouracil in a mouse model of human pancreatic and ovarian cancer. Thus, over sixty years after the discovery of the first TS prodrug inhibitor, fluorouracil, E7 breaks the link between TS inhibition and enhanced expression in response, providing a strategy to fight drug-resistant cancers.

    针对人类胸苷酸合成酶(hTS)这种二聚酶的药物被广泛用于抗癌治疗。然而,使用传统的底物位点定向 TS 抑制剂治疗会诱导这种蛋白质的过度表达并产生耐药性。因此,我们另辟蹊径,发现了 TS 二聚体脱稳剂。这些化合物与单体-单体界面结合,使重组蛋白和细胞内蛋白的二聚化平衡向非活性单体转移。结构、光谱和动力学研究为这些小分子与 hTS 的相互作用效果提供了证据和定量信息。我们重点研究了其中的佼佼者 E7,结果表明它能抑制癌细胞中的 hTS,并加速其蛋白酶体降解,从而降低酶在细胞内的水平。在人类胰腺癌和卵巢癌小鼠模型中,E7 的抗癌效果也优于氟尿嘧啶。因此,在发现第一种TS原药抑制剂氟尿嘧啶六十多年后,E7打破了TS抑制与反应表达增强之间的联系,为抗击耐药性癌症提供了一种策略。
  • Nickel-Catalyzed Intramolecular Dual Annulation Reaction of Aryl Nitrile-Containing 1,2,3-Benzotriazin-4(3<i>H</i>)-ones: A Pathway To Synthesize Luotonin A and Related Polycyclic Pyrroloquinazolinones
    作者:Vijaykumar H. Thorat、Jen-Chieh Hsieh
    DOI:10.1021/acs.orglett.3c03142
    日期:2023.11.10
    Herein, we report a nickel-catalyzed intramolecular denitrogenative dual annulation reaction of aryl nitrile-containing 1,2,3-benzotriazine-4(3H)-ones to synthesize polycyclic pyrroloquinazolinones with a tolerance of a wide diversity of substituents. This catalytic reaction is the first denitrogenative transannulation of 1,2,3-benzotriazine-4(3H)-one with nitrile, which can be applied as the critical
    在此,我们报道了含芳基腈的1,2,3-苯并三嗪-4(3 H )-酮的镍催化分子内脱氮双环化反应,合成了具有多种取代基的多环吡咯并喹唑啉酮。该催化反应是1,2,3-苯并三嗪-4(3H)-酮与腈的首次脱氮转环反应,可作为合成洛托宁A的关键步骤,具有较高的步骤经济性。
  • [EN] NEUROTRYPSIN INHIBITORS<br/>[FR] INHIBITEURS DE LA NEUROTRYPSINE
    申请人:NEUROTUNE AG
    公开号:WO2012059442A3
    公开(公告)日:2012-09-27
  • A biotin-conjugated pyridine-based isatoic anhydride, a selective room temperature RNA-acylating agent for the nucleic acid separation
    作者:S. Ursuegui、R. Yougnia、S. Moutin、A. Burr、C. Fossey、T. Cailly、A. Laayoun、A. Laurent、F. Fabis
    DOI:10.1039/c4ob02636e
    日期:——

    A biotin-conjugated pyridine based isatoic anhydride has been designed and evaluated for nucleic acid separation after RNA 2′-OH acylation at room temperature.

    一种与生物素偶联的基于吡啶的异酰亚胺已被设计并在室温下评估,用于RNA 2'-OH酰化后的核酸分离。
查看更多